We assume that in the analysed HNSCC cells TPCA1 is the only inhibitor that efficiently inhibits the classical NFκB pathway—TPCA1 alone was able to inhibit IL-8 secretion. This evidence concerns the gene CXCL8 and head and neck squamous cell carcinoma.